Raman Prakash Acquires Stock Option in Black Diamond Therapeutics

On June 26, 2026, Raman Prakash, a director at Black Diamond Therapeutics, Inc. (BDTX), acquired a stock option to purchase 40,000 shares of Common Stock. The option has an exercise price of $1.71 per share and is exercisable upon the earlier of June 26, 2027, or the company's next annual meeting of stockholders, provided Mr. Prakash continues his service. The option expires on June 25, 2036. This transaction is reported on Form 4.